BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

668 related articles for article (PubMed ID: 17189091)

  • 21. [A mass-spectrometric analysis of genetic markers of S. pneumoniae resistance to beta-lactam antibiotics].
    Savinova TA; Il'ina EN; Sidorenko SV
    Mol Gen Mikrobiol Virusol; 2010; (3):16-25. PubMed ID: 20882772
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Highly variable penicillin resistance determinants PBP 2x, PBP 2b, and PBP 1a in isolates of two Streptococcus pneumoniae clonal groups, Poland 23F-16 and Poland 6B-20.
    Izdebski R; Rutschmann J; Fiett J; Sadowy E; Gniadkowski M; Hryniewicz W; Hakenbeck R
    Antimicrob Agents Chemother; 2008 Mar; 52(3):1021-7. PubMed ID: 18160523
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Major related sets of antibiotic-resistant Pneumococci in the United States as determined by pulsed-field gel electrophoresis and pbp1a-pbp2b-pbp2x-dhf restriction profiles.
    Gherardi G; Whitney CG; Facklam RR; Beall B
    J Infect Dis; 2000 Jan; 181(1):216-29. PubMed ID: 10608770
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distribution and antibacterial susceptibility of macrolide resistance genotypes in Streptococcus pneumoniae: PROTEKT Year 5 (2003-2004).
    Farrell DJ; Couturier C; Hryniewicz W
    Int J Antimicrob Agents; 2008 Mar; 31(3):245-9. PubMed ID: 18178388
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular basis and clonal nature of increasing pneumococcal macrolide resistance in South Africa, 2000-2005.
    Wolter N; von Gottberg A; du Plessis M; de Gouveia L; Klugman KP;
    Int J Antimicrob Agents; 2008 Jul; 32(1):62-7. PubMed ID: 18339522
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High prevalence of Streptococcus pneumoniae with mutations in pbp1a, pbp2x, and pbp2b genes of penicillin-binding proteins in the nasopharynx in children in Japan.
    Hotomi M; Billal DS; Shimada J; Suzumoto M; Yamauchi K; Fujihara K; Yamanaka N
    ORL J Otorhinolaryngol Relat Spec; 2006; 68(3):139-45. PubMed ID: 16462149
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activity of ceftobiprole against Streptococcus pneumoniae isolates exhibiting high-level resistance to ceftriaxone.
    Davies TA; Flamm RK; Lynch AS
    Int J Antimicrob Agents; 2012 Jun; 39(6):534-8. PubMed ID: 22526015
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Beta-lactam and macrolide resistance in Streptococcus pneumoniae].
    Shibasaki Y; Ubukata K
    Nihon Rinsho; 2001 Apr; 59(4):681-6. PubMed ID: 11304989
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evolution of macrolide resistance in Streptococcus pneumoniae clinical isolates in the prevaccine era.
    Daikos GL; Koutsolioutsou A; Tsiodras S; Theodoridou M; Koutouzis EI; Charissiadou A; Pangalis A; Michos AG; Chaidopoulou F; Braoudaki M; Syriopoulou VP
    Diagn Microbiol Infect Dis; 2008 Apr; 60(4):393-8. PubMed ID: 18077121
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro activity of beta-lactams, macrolides, telithromycin, and fluoroquinolones against clinical isolates of Streptococcus pneumoniae: correlation between drug resistance and genetic characteristics.
    Yamaguchi T; Hashikita G; Takahashi S; Itabashi A; Yamazaki T; Maesaki S
    J Infect Chemother; 2005 Oct; 11(5):262-4. PubMed ID: 16258826
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distribution of capsular serotypes and macrolide resistance mechanisms among macrolide-resistant Streptococcus pneumoniae isolates in Korea.
    Bae S; Lee K
    Diagn Microbiol Infect Dis; 2009 Feb; 63(2):213-6. PubMed ID: 19097840
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activities of ceftobiprole and other beta-lactams against Streptococcus pneumoniae clinical isolates from the United States with defined substitutions in penicillin-binding proteins PBP 1a, PBP 2b, and PBP 2x.
    Davies TA; Shang W; Bush K
    Antimicrob Agents Chemother; 2006 Jul; 50(7):2530-2. PubMed ID: 16801437
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of pbp2b and ermB genes in clinical isolates of Streptococcus pneumoniae.
    Kumari N; Navaratnam P; Sekaran SD
    J Infect Dev Ctries; 2008 Jun; 2(3):193-9. PubMed ID: 19738350
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Breakthrough in penicillin resistance? Streptococcus pneumoniae isolates with penicillin/cefotaxime MICs of 16 mg/L and their genotypic and geographical relatedness.
    Soriano F; Cafini F; Aguilar L; Tarragó D; Alou L; Giménez MJ; Gracia M; Ponte MC; Leu D; Pana M; Letowska I; Fenoll A
    J Antimicrob Chemother; 2008 Dec; 62(6):1234-40. PubMed ID: 18799472
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Analysis of antimicrobial resistance of Streptococcus pneumoniae with restriction fragment length polymorphism of pbp2b gene and pulsed-field gel electrophoresis profiles among children].
    Yu SJ; Hu YY; Gao W; Wang JF; Yang YH
    Zhonghua Er Ke Za Zhi; 2003 Sep; 41(9):688-91. PubMed ID: 14733813
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Study on the molecule epidemiological between resistances of 7 genes interrelated 4 antibiotic to isolated Streptococcus pneumoniae in children].
    Ding YF; Mi ZH; Zhang JH; Tao YZ; Qin L
    Zhonghua Liu Xing Bing Xue Za Zhi; 2005 Jun; 26(6):435-9. PubMed ID: 16185459
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Macrolide and azithromycin use are linked to increased macrolide resistance in Streptococcus pneumoniae.
    Bergman M; Huikko S; Huovinen P; Paakkari P; Seppälä H;
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3646-50. PubMed ID: 16940064
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discrepancy between antibiotics administered in acute exacerbations of chronic bronchitis and susceptibility of isolated pathogens in respiratory samples: multicentre study in the primary care setting.
    Querol-Ribelles JM; Molina J; Naberan K; Esteban E; Herreras A; Garcia-de-Lomas J
    Int J Antimicrob Agents; 2006 Nov; 28(5):472-6. PubMed ID: 17046209
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Characterization of macrolide-resistance mediated by transposable elements Tn1545 and Tn917 in clinical Isolates of Streptococcus pneumoniae].
    Wu WJ; Hong XH; Zhang H; Jiang YQ; Lu Q; Ni YX
    Zhonghua Yi Xue Za Zhi; 2006 Mar; 86(9):605-8. PubMed ID: 16681905
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effects of amino acid substitutions of penicillin-binding proteins 2B, 1A, 2X on minimal inhibitory concentration of beta-lactams against Streptococcus pneumoniae].
    Xu M; Zhang JH; Ding YF; Tao YZ; Wang ZC
    Zhonghua Er Ke Za Zhi; 2010 Jan; 48(1):60-4. PubMed ID: 20441706
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.